Haifa Rachdi
Overview
Explore the profile of Haifa Rachdi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ennouri S, Daoud N, Berrazegua Y, El Benna H, Korbi S, Rachdi H, et al.
Acta Clin Croat
. 2025 Feb;
63(1):80-88.
PMID: 39959318
We aimed to explore variations in dietary habits in cancer patients according to clinical and demographic characteristics. We conducted a cross-sectional survey on cancer patients treated with systemic therapy. The...
2.
Berrazaga Y, Rachdi H, Saadi M, Haouari A, Fendri S, Daoud N, et al.
J Adolesc Young Adult Oncol
. 2024 Apr;
13(3):541-547.
PMID: 38579135
This study aimed to explore the experiences of young adult cancer patients within the Tunisian context. A total of 104 patients between the ages of 20 and 40, undergoing treatment...
3.
Jandoubi N, Boujemaa M, Mighri N, Mejri N, Ben Nasr S, Bouaziz H, et al.
Transl Oncol
. 2024 Feb;
43:101912.
PMID: 38387387
Cancer management in Africa faces diverse challenges due to limited resources, health system challenges, and other matters. Identifying hereditary cancer syndromic cases is crucial to improve clinical management and preventive...
4.
Boujemaa M, Nouira F, Jandoubi N, Mejri N, Bouaziz H, Charfeddine C, et al.
Front Genet
. 2024 Feb;
15:1327894.
PMID: 38313678
Recent advances in sequencing technologies have significantly increased our capability to acquire large amounts of genetic data. However, the clinical relevance of the generated data continues to be challenging particularly...
5.
Mejri N, Lajnef I, Berrazega Y, Rachdi H, Bohli M, Kochbati L, et al.
Support Care Cancer
. 2023 Jan;
31(2):103.
PMID: 36622425
Purpose: The aim of the present study was to measure the frequency and types of IPV among patients with cancer and evaluate risk factors. Methods: The study was a cross-sectional,...
6.
Mighri N, Mejri N, Boujemaa M, Berrazega Y, Rachdi H, El Benna H, et al.
PLoS One
. 2022 Sep;
17(9):e0269732.
PMID: 36094928
Breast cancer has different epidemio-clinical characteristics in Middle East and North-African populations compared to those reported in the Western countries. The aim of this study is to analyze the epidemiological...
7.
Abdallah I, Rachdi H, Mejri N, Berrazega Y, Laabidi S, Boussen H
BMJ Support Palliat Care
. 2022 Apr;
PMID: 35383047
Objective: Previous data hypothesise that women receiving aromatase inhibitors (AIs) exhibit worse cognitive functioning than patients on tamoxifen (TAM) since their oestrogen levels are lower. We aimed to compare cognitive...
8.
Abdallah I, Berrazega Y, Rachdi H, Mejri N, Neji H, Daoud N, et al.
J Oncol Pharm Pract
. 2022 Jan;
28(6):1446-1449.
PMID: 35068260
Introduction: Drug-induced acute pancreatitis (AP) is uncommon and represents 0.1 to 2% of all AP cases. Chemotherapy-induced AP is very rare. Docetaxel monotherapy-induced AP has been reported only once in...
9.
Mejri N, Rachdi H, Mnif A, Berrazega Y, El Benna H, Labidi S, et al.
J Nurs Meas
. 2021 Sep;
30(4):673-682.
PMID: 34518422
We aimed to translate the Comprehensive Score of Financial Toxicity (COST) questionnaire into Arabic and to evaluate its reliability and validity. We applied the four-step translation method and conducted a...
10.
Hamdi Y, Mighri N, Boujemaa M, Mejri N, Ben Nasr S, Ben Rekaya M, et al.
Front Oncol
. 2021 Sep;
11:674965.
PMID: 34490083
Background: Breast cancer is the world's most common cancer among women. It is becoming an increasingly urgent problem in low- and middle-income countries (LMICs) where a large fraction of women...